Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on Key Techniques for Intelligent Diagnosis and Ablation Decision-making of Liver Cancer and Evolution by Contrast-enhanced Ultrasound

NCT04682886 is registered in ClinicalTrials.gov with Ping Liang as lead sponsor.

NCT NCT04682886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04682886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on Key Techniques for Intelligent Diagnosis and Ablation Decision-making of Liver Cancer and Evolution by Contrast-enhanced Ultrasound
Lead sponsor
Ping Liang
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2017
Completion date
December 31, 2025
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast-enhanced ultrasound, focal liver lesions